FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC
from Lung Cancer Considered Hosted by IASLC
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Lung Cancer Considered?
This episode is 45 minutes long.
When was this Lung Cancer Considered episode published?
This episode was published on July 18, 2025.
Can I download this Lung Cancer Considered episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.